ロード中...
Case series of six kidney transplanted patients with COVID‐19 pneumonia treated with tocilizumab
Few reports described the outcome of kidney transplanted patients (KTs) affected by COVID‐19 treated with interleukin‐6 receptor inhibitor tocilizumab (TCZ). We report our case series of 6 KTs with COVID‐19 pneumonia who received TCZ: All were of male gender, with a mean age of 55.5 ± 8.4 years, a m...
保存先:
| 出版年: | Transpl Infect Dis |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7300504/ https://ncbi.nlm.nih.gov/pubmed/32500936 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/tid.13348 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|